Connection

Marek Jutel to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Marek Jutel has written about Antibodies, Monoclonal.
Marek Jutel
Connection Strength
0.044
Antibodies, Monoclonal
  1. A Randomized, Placebo-Controlled Phase 2 Trial of CNTO 6785 in Chronic Obstructive Pulmonary Disease. COPD. 2017 Oct; 14(5):476-483.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.